A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Clinical trial NCT00953147 · COMPLETED

Trial details

NCT number: NCT00953147
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis Perennial Allergic Rhinitis

Start date: 2009-08-01
Primary completion: 2010-01-01
Enrollment: 1110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.